The Next Frontier: Value-Based Partnerships

Medisafe is introducing a new form of partnership to propel our collaboration with partners to the next level.

We have proven that Medisafe increases medication refills rates, evidence that is backed by statistically and clinically significant findings from a comprehensive multi-therapeutic area study matching de-identified Medisafe users to their prescription claims.

We are using this same data to forecast the revenue impact to your brand of working with Medisafe, as well as to design an ROI model that competes with or outperforms your most profitable initiatives. And throughout our collaboration, you can rest assured, Medisafe’s success is directly tied to yours.

Creating Value Together

Our research shows that patients who use Medisafe for at least 60 days and take a depression medication fill an additional 4.5 times per year. See how much value Medisafe can generate for Brand X in this therapeutic category:

Assuming a revenue per fill of $200 (WAC – discounts and operational costs), Brand X can generate over $2M in additional revenue by partnering with Medisafe. And because Medisafe offers a new value-based model, there is limited risk if the collaboration does not perform to expectations.

You may also like

Protected: Demo by Medisafe Aug 6 025

There is no excerpt because this is a protected post.

..Read More

80% Pharma Price Cuts? A New Era of Performance-Driven Patient Engagement for Agencies

The second half of 2025 brings an increasingly pressurized pharmaceutical landscape marked by potential federal mandates to slash US drug 

..Read More

Transforming Breast Cancer Care: Proven Adherence Gains for Pharma Execs

Summary Breast cancer remains one of the most prevalent malignancies worldwide, with an estimated 287,850 new invasive cases and 43,250 

..Read More

Want to Learn More?

We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.